Skip to main content

Advertisement

Log in

REM sleep behavioral disorder may be an independent risk factor for orthostatic hypotension in Parkinson’s disease

  • Original Article
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was to evaluate the association between clinically possible rapid eye movement (REM) sleep behavioral disorder (pRBD) and orthostatic hypotension (OH) in PD patients, as well as to explore the mechanisms underlying the association.

Methods

PD patients (n = 116) were assigned to a group with OH (PD-OH) or without OH (PD-NOH). General demographic and clinical data were collected. A series of scales were used to assess the clinical symptoms in the two groups.

Results

A total of 27 patients (23.3%) had OH. The PD-OH group showed significantly higher H-Y staging score and significantly higher frequencies of pRBD, anxiety, depression, and cognitive impairment than the PD-NOH group. Binary logistic regression analysis identified the following factors as independently associated with PD-OH: H-Y staging [odds ratio (OR) 2.565, 95% confidence interval (CI) 1.160–5.673; P = 0.020], RBD (OR 7.680, 95% CI 1.944–30.346; P = 0.004), UPDRS II (OR 1.021, 95% CI 0.980–1.063; P = 0.020), depression (OR 7.601, 95% CI 1.492–38.718; P = 0.015), and cognitive impairment (OR 0.824, 95% CI 0.696–0.976; P = 0.025).

Conclusions

Our results suggest that pRBD is an independent risk factor for OH in patients with PD. We speculate that there may be a close relationship between RBD and OH, which requires attention. Early diagnosis of RBD may help predict the appearance of OH in PD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Coon EA, Cutsforth-Gregory JK, Benarroch EE (2018) Neuropathology of autonomic dysfunction in synucleinopathies. Mov Disord 33:349–358

    Article  Google Scholar 

  2. Fereshtehnejad SM, Lokk J (2014) Orthostatic hypotension in patients with Parkinson’s disease and atypical parkinsonism. Parkinsons Dis 2014:475854

    PubMed  PubMed Central  Google Scholar 

  3. Sara SJ (2009) The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci 10:211–223

    Article  CAS  Google Scholar 

  4. St Louis EK, Boeve AR, Boeve BF (2017) REM sleep behavior disorder in Parkinson’s disease and other synucleinopathies. Mov Disord 32:645–658

    Article  CAS  Google Scholar 

  5. Högl B, Stefani A, Videnovic A (2018) Idiopathic REM sleep behaviour disorder and neurodegeneration—an update. Nat Rev Neurol 14:40–55

    Article  Google Scholar 

  6. Ng M, Pavlova M (2013) Why are seizures rare in rapid eye movement sleep? Review of the frequency of seizures in different sleep stages. Epilepsy Res Treat 2013:932790

    PubMed  PubMed Central  Google Scholar 

  7. Jain S, Goldstein DS (2012) Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis. Neurobiol Dis 46:572–580

    Article  CAS  Google Scholar 

  8. Arnaldi D, De Carli F, Famà F et al (2017) Prediction of cognitive worsening in de novo Parkinson’s disease: clinical use of biomarkers. Mov Disord 32:1738–1747

    Article  Google Scholar 

  9. Joong-Seok K, Hyung-Eun P, Yoon-Sang O et al (2016) Orthostatic hypotension and cardiac sympathetic denervation in Parkinson disease patients with REM sleep behavioral disorder. J Neurol Sci 362:59–63

    Article  Google Scholar 

  10. Fereshtehnejad S-M, Romenets SR, Anang JBM et al (2015) New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol 72:863–873

    Article  Google Scholar 

  11. Pilotto A, Romagnolo A, Tuazon Jasmine A et al (2019) Orthostatic hypotension and REM sleep behaviour disorder: impact on clinical outcomes in α-synucleinopathies. J Neurol Neurosurg Psychiatry 90:1257–1263

    Article  Google Scholar 

  12. Goldman JG, Holden SK, Litvan I et al (2018) Evolution of diagnostic criteria and assessments for Parkinson’s disease mild cognitive impairment. Mov Disord 33:503–510

    Article  Google Scholar 

  13. Pilotto A, Premi E, Paola Caminiti S et al (2018) Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease. Neurology 90:e1029–e1037

    Article  Google Scholar 

  14. Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson‘s disease. Mov Disord 30:1591–1601

    Article  Google Scholar 

  15. Freeman R, Wieling W, Axelrod FB et al (2011) Consensus statement on the defifinition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 21:69–72

    Article  Google Scholar 

  16. Choe YM, Lee B, Choi I-G et al (2020) MMSE subscale scores as useful predictors of AD conversion in mild cognitive impairment. Neuropsychiatr Dis Treat 16:1767–1775

    Article  Google Scholar 

  17. Hussain MW, Camicioli R (2018) Nonmotor symptoms of Parkinson’s disease as predictors of dementia. Can J Neurol Sci 45:97–99

    Article  Google Scholar 

  18. Tanaka R, Shimo Y, Yamashiro K et al (2018) Association between abnormal nocturnal blood pressure profile and dementia in Parkinson’s disease. Parkinsonism Relat Disord 46:24–29

    Article  Google Scholar 

  19. Li L, Guo P, Ding D et al (2019) Parkinson’s disease with orthostatic hypotension: analyses of clinical characteristics and influencing factors. Neurol Res 41:734–741

    Article  CAS  Google Scholar 

  20. Bonuccelli U, Lucetti C, Del Dotto P et al (2003) Orthostatic hypotension in de novo Parkinson disease. Arch Neurol 60:1400–1404

    Article  Google Scholar 

  21. Lee HM, Koh SB (2015) Many faces of Parkinson’s disease: non-motor symptoms of Parkinson’s disease. J Mov Disord 8:92–97

    Article  Google Scholar 

  22. Hohler AD, Zuzuárregui JR, Katz DI et al (2012) Differences in motor and cognitive function in patients with Parkinson’s disease with and without orthostatic hypotension. Int J Neurosci 122:233–236

    Article  Google Scholar 

  23. Rose KM, Couper D, Eigenbrodt ML et al (2010) Orthostatic hypotension and cognitive function: the atherosclerosis risk in communities study. Neuroepidemiology 34:1–7

    Article  Google Scholar 

  24. Senard JM, Valet P, Durrieu G et al (1990) Adrenergic supersensitivity in Parkinsonians with orthostatic hypotension. Eur J Clin Invest 20:613–619

    Article  CAS  Google Scholar 

  25. Choi MH, Yoon JH, Yong SW (2017) Cardiac sympathetic denervation and dementia in de novo Parkinson’s disease: a 7-year follow-up study. J Neurol Sci 381:291–295

    Article  Google Scholar 

  26. Haubrich C, Pies K, Dafotakis M et al (2010) Transcranial doppler monitoring in Parkinson’s disease: cerebrovascular compensation of orthostatic hypotension. Ultrasound Med Biol 36:1581–1587

    Article  Google Scholar 

  27. Centi J, Freeman R, Gibbons CH et al (2017) Effects of orthostatic hypotension on cognition in Parkinson disease. Neurology 88:17–24

    Article  Google Scholar 

  28. Oh YS, Kim JS, Lee KS (2013) Orthostatic and supine blood pressures are associated with white matter hyperintensities in Parkinson disease. J Mov Disord 6:23–27

    Article  Google Scholar 

  29. Perlmuter LC, Sarda G, Casavant V et al (2013) A review of the etiology, associated comorbidities, and treatment of orthostatic hypotension. Am J Ther 20:279–291

    Article  Google Scholar 

  30. Broen MP, Narayen NE, Kuijf ML et al (2016) Prevalence of anxiety in Parkinson’s disease: a systematic review and meta-analysis. J Mov Disord Soc 31:1125–1133

    Article  Google Scholar 

  31. Reijnders JS, Ehrt U, Weber WE et al (2008) A systematic review of prevalence studies of depression in Parkinson’s disease. J Mov Disord Soc 23:183–189

    Article  Google Scholar 

  32. Bayulkem K, Lopez G (2010) Nonmotor flfluctuations in Parkinson’s disease: clinical spectrum and classifification. J Neurol Sci 289:89–92

    Article  Google Scholar 

  33. Hu X, Song X, Yuan Y et al (2015) A bnormal functional connectivity of the amygdala is associated with depression in Parkinson’sdisease. Mov Disord 30:238–244

    Article  Google Scholar 

  34. Weintraub D, Newberg AB, Cary MS et al (2005) Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson’s disease. J Nucl Med 46:227–232

    CAS  PubMed  Google Scholar 

  35. Rudorfer MV, Ross R, Linnoila M et al (1985) Exaggerated orthostatic responsivity of plasma norepinephrine in depression. Arch Gen Psychiatry 42:1186–1192

    Article  CAS  Google Scholar 

  36. Voss A, Schulz BV, Bar KJ (2006) Linear and nonlinear methods for analyses of cardiovascular variability in bipolar disorders. Bipolar Disord 8:441–452

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank the Parkinson’s disease patients for their participation in our study.

Funding

This work was funded by the National Natural Science Foundation of China (grant number 81960242), Yunnan Applied Basic Research Project (grant numbers 2019FE001-048 and 202001AT070001), Yunnan Provincial Health Science and Technology Project (grant number 2018NS0102), The Applied Basic Research of The Diagnosis and Treatment Center of Neurological Diseases in Yunnan Province (grant number ZX2019-03-05) and the 100 Young and Middle-aged Academic and Technical Scholars at Kunming Medical University (grant number 60118260105).

Author information

Authors and Affiliations

Authors

Contributions

KFY contributed to the acquisition of the data, statistical analysis, and interpretation of the data, and drafted the manuscript. ZX and XLY contributed to the study concept and design, acquisition of the data, statistical analysis, and critical revision of the manuscript for important intellectual content. YYZ, WFY, CBZ, LY, YFZ, BL and HR contributed to the acquisition of the data and clinical assessment.

Corresponding author

Correspondence to Xinglong Yang.

Ethics declarations

Conflicts of interest

All authors state that they have no conflicts of interest to declare.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards declaration and its later amendments or comparable ethical standards.

Consent to participate

Written informed consent was obtained from all patients and their families for their anonymized clinical data to be published for research purposes.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yin, K., Zhou, C., Zhu, Y. et al. REM sleep behavioral disorder may be an independent risk factor for orthostatic hypotension in Parkinson’s disease. Aging Clin Exp Res 34, 159–166 (2022). https://doi.org/10.1007/s40520-021-01887-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40520-021-01887-y

Keywords

Navigation